McKesson Corp. Stock
Price
Target price
€511.40
€511.40
1.300%
6.6
1.300%
€550.00
22:26 / Tradegate
WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
McKesson Corp. Stock
McKesson Corp. gained 1.300% today.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 550 € shows a slightly positive potential of 7.55% compared to the current price of 511.4 € for McKesson Corp..
Pros and Cons of McKesson Corp. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| McKesson Corp. | 1.300% | 0.198% | 2.987% | 40.778% | 22.415% | 215.468% | 347.861% |
| Cardinal Health Inc. | 1.140% | -1.588% | -11.404% | 13.794% | -0.822% | 92.412% | 116.729% |
| CVS Health Corp. | 2.340% | 1.114% | -20.296% | -18.320% | -27.806% | -25.518% | 10.171% |
| AmerisourceBergen Corp. | -0.120% | -2.254% | -7.530% | 27.918% | 10.812% | 112.344% | 199.735% |
Comments
McKesson Co. (NYSE: MCK) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $547.00 to $545.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Barclays PLC from $571.00 to $596.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at TD Cowen from $563.00 to $652.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
News
McKesson (MCK) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
McKesson (NYSE: MCK)Q4 2024 Earnings CallMay 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com
McKesson (MCK) Q3 2024 Earnings Call Transcript
Image source: The Motley Fool.
McKesson (NYSE: MCK)Q3 2024 Earnings CallFeb 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. While investors usually look to such